Sign In
Buy ALLK
$0.329
+0 (+0%)
At Close: Aug 14, 2025
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting
12:01pm, Tuesday, 21'st Apr 2020
REDWOOD CITY, Calif., April 21, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and.
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting
12:01pm, Tuesday, 21'st Apr 2020
REDWOOD CITY, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab...
Allakos Inc (NASDAQ:ALLK) Expected to Announce Earnings of -$0.62 Per Share
10:16am, Tuesday, 21'st Apr 2020
Equities research analysts expect that Allakos Inc (NASDAQ:ALLK) will announce earnings per share of ($0.62) for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Allako
LOS ANGELES, CA / ACCESSWIRE / April 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "t
Nuveen Asset Management LLC Grows Stock Holdings in Allakos Inc (NASDAQ:ALLK)
10:56am, Monday, 20'th Apr 2020
Nuveen Asset Management LLC grew its holdings in Allakos Inc (NASDAQ:ALLK) by 6.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK
10:08pm, Saturday, 18'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 18, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Allakos Inc. ("Allakos" or the "Company") (NASDAQ: ALLK). Such investors ...
LOS ANGELES, CA / ACCESSWIRE / April 17, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "t
NEW YORK, NY / ACCESSWIRE / April 16, 2020 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities clas
SAN FRANCISCO, April 15, 2020 -- Hagens Berman urges Allakos Inc. (NASDAQ: ALLK) investors who have suffered significant losses to submit their losses now. A securities fraud.
NEW YORK, April 15, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019.
LOS ANGELES, CA / ACCESSWIRE / April 14, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Allakos Inc. ("Allakos" or "t
BRIEF-Allakos Inc Entered 10-Year Commercial Supply Agreement With Lonza Sales AG
08:22pm, Monday, 13'th Apr 2020
Allakos Inc:
Notice of Lead Plaintiff Deadline for Shareholders in the Allakos Inc. Securities Class Action Lawsuit
01:00pm, Monday, 13'th Apr 2020
Robbins Geller Rudman & Dowd LLP announces that the lead plaintiff motion deadline in the Allakos securities class action lawsuit is May 11, 2020. A securities class action lawsuit was filed in the No
Allakos Inc (NASDAQ:ALLK) Shares Sold by Man Group plc
10:10am, Monday, 13'th Apr 2020
Man Group plc cut its stake in Allakos Inc (NASDAQ:ALLK) by 85.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,525
Cubist Systematic Strategies LLC Has $351,000 Holdings in Allakos Inc (NASDAQ:ALLK)
09:30am, Monday, 13'th Apr 2020
Cubist Systematic Strategies LLC reduced its position in Allakos Inc (NASDAQ:ALLK) by 20.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange
